Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
15% Patients lost an average of 15% of their body weight in ~1 year.* *In a 68-week double-blind trial studying once-weekly semaglutide injections (2.4 mg) in 1,961 patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15%, when paired with diet and exercise changes
When you eat smaller portions during the day, your stomach does not have to work so hard
Most patients begin with 2.5 mg once weekly for four weeks
A third Novo Nordisk drug containing semaglutide, Rybelsus, is prescribed to treat type 2 diabetes but is also commonly used for weight loss
Cancer risk rises across multiple sites: endometrial, pancreatic, kidney, postmenopausal breast
Semaglutide is a revolutionary injectable medication designed for chronic weight management
